Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 737-738, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krapf, F. E.
Right arrow Articles by Harris, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krapf, F. E.
Right arrow Articles by Harris, D. L.
Related Collections
Right arrow Laboratory Management
(Clinical Chemistry. 2000;46:737-738.)
© 2000 American Association for Clinical Chemistry, Inc.

Letters

Stability of Clinical Chemistry Analytes in Blood Collection Devices

Friedel E. Krapf1

1 IML Immunologisch-, Medizinisches Labor, Am Tower 11, D-90475 Nürnberg, Germany, Fax 49-9128-920381, E-mail iml@labor-krapf.de


To the Editor:

During the AACC Annual Meeting in New Orleans in July 1999, Greiner Meditech Inc. (Bel Air, MD), distributed sample packages with labeling claiming that their serum and plasma Vacuette® blood collection tubes with clot activator and separation gel for clinical chemistry analyses are capable of maintaining the stability of all analytes during storage for 48 h without affecting the serum or plasma values (1). I found similar 48-h stability claims for the Vacuette blood collection devices on Greiner’s Web sites in the United States and Europe (2)(3). In addition, colleagues in laboratories in Spain had received Greiner Vacuette product information with universal 48-h stability claims (4). Data supporting the claims described above were not provided in any of the above instances and could not be found during an . . . [Full Text of this Article]


References

Douglas L. Harris2

2 Greiner-VACUETTE® North America, PO Box 943, Bel Air, MD 21014, E-mail greinermed@aol.com


To the Editor:






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.